The 9th China (Tianjin) Nucleic Acid Drug Conference focuses on nucleic acid drug research and development, industrialization, and global cooperation. It brings together academicians, pharmaceutical companies, regulatory agencies, and international experts to build an “industry-academia-research-application-management-investment” ecosystem and promote a new era of precision medicine.
Join the 2025 Korea CPHI Exhibition & bio conf (August 26-28, Seoul COEX) and explore S. Korea’s $21.5B pharma market! Meet 360+ exhibitors in APIs, biopharma & equipment; access 65-country buyers & B2B matchmaking. Gain insights into Korea’s “Biopharm 2030” initiative opportunities.
Join over 800 global experts to explore breakthroughs in cancer immunotherapy, biomarker-driven drug development, and AI-enabled companion diagnostics innovation. Connect with leaders in pharmaceuticals, diagnostics, and clinical practice to shape the future of precision medicine.
Bio Conference 2025 (CBI): 3 key whitepapers, actionable tips for biotech R&D pipelines, investment tweaks & regulatory moves—turn takeaways into your next impactful decision.
